Division of Urology, Department of Surgery, Faculty of Medicine and Health Sciences, Walter Sisulu University, East London, South Africa; Division of Urology, Department of Surgery, Faculty of Health Sciences, University of Cape Town, South Africa.
Division of Urology, Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
S Afr Med J. 2024 May 9;114(5):e2194. doi: 10.7196/SAMJ.2024.v114i5.2194.
Prostate cancer (PCa) is the most widespread solid organ malignancy in males and ranks as the fifth leading cause of death globally. Identifying and treating men with clinically significant disease while avoiding the over-diagnosis and over-treatment of indolent disease remains a significant challenge. Several professional associations have developed guidelines on screening and early diagnosis of asymptomatic men with prostate-specific antigen testing. With recent updates from several large randomised prospective trials, the South African Urological Association and the Prostate Cancer Foundation of South Africa have developed these evidence-based recommendations to guide clinicians on PCa screening and early diagnosis for South African men.
前列腺癌(PCa)是男性中最常见的实体器官恶性肿瘤,也是全球第五大致死原因。确定并治疗具有临床意义的疾病,同时避免对惰性疾病的过度诊断和过度治疗仍然是一个重大挑战。一些专业协会已经制定了关于使用前列腺特异性抗原检测筛查无症状男性和早期诊断的指南。随着最近几项大型随机前瞻性试验的更新,南非泌尿科协会和南非前列腺癌基金会制定了这些基于证据的建议,以指导南非男性的 PCa 筛查和早期诊断。